http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104363924-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6907 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-60 |
| filingDate | 2013-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104363924-B |
| titleOfInvention | Control for delivering 1 inhibitor of HIF discharges composite |
| abstract | The Controlled release formulation amount composite for being used for delivering one or more 1 inhibitor of HIF is provided.The control release composite contains one or more and is incorporated into or is scattered in 1 inhibitor of HIF in polymer mediator.In some cases, one or more 1 inhibitor of HIF are dispersed in or are packaged in polymer substrate.In a preferred embodiment, one or more described 1 inhibitor of HIF are covalently bonded in polymer, form polymeric medicine conjugate.Polymer mediator can form the implant for administering, particulate, nano-particle or its combination.Control release 1 composites of HIF provide long-term treatment benefit by discharging one or more 1 inhibitor of HIF and/or 1 inhibitor conjugates of HIF of low content within an elongated segment period, while reduce side effect.Controlled release formulation amount composite for delivering one or more 1 inhibitor of HIF can be used for treating or preventing disease or illness related with vascularization in patient, including cancer, obesity and eye disease, such as moist AMD. |
| priorityDate | 2012-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 469.